Approximation error

AdventHealth West Florida Hospitals Earn 'All A's in Tampa Bay' for Hospital Safety Grades from The Leapfrog Group

Retrieved on: 
Thursday, November 9, 2023
AdventHealth, Patient safety organization, Accreditation Council for Graduate Medical Education, Leapfrog, Obstetrics, Gynaecology, Health, Volunteering, Injury, Internal medicine, Hospital, Straight, Accident, Culture, Safety, Graduate medical education, Approximation error, Patient, Infection, Nursing, Tampa Bay, AdventHealth Ocala

TAMPA, Fla., Nov. 9, 2023 /PRNewswire/ -- Once again, all AdventHealth West Florida Division hospitals in the Tampa Bay area have earned an "A" Hospital Safety Grade from The Leapfrog Group, a national nonprofit watchdog organization that sets standards for excellence in patient care. Leapfrog assigns an "A," "B," "C," "D" or "F" grade to general hospitals across the country based on over 30 national performance measures reflecting errors, accidents, injuries and infections, as well as the systems hospitals have in place to prevent harm to patients.

Key Points: 
  • These "A" hospitals in Tampa Bay include AdventHealth Carrollwood, AdventHealth Dade City, AdventHealth North Pinellas, AdventHealth Tampa, AdventHealth Wesley Chapel and AdventHealth Zephyrhills.
  • AdventHealth Lake Placid and AdventHealth Sebring in Highlands County, as well as AdventHealth Ocala in Marion County, also achieved 'A' ratings from The Leapfrog Group.
  • "We're honored to receive Straight 'A' grades from The Leapfrog Group in Tampa Bay, validating our commitment to patient safety and the best clinical outcomes," said Dr. Robin McGuinness, AdventHealth West Florida Division Chief Nursing Executive.
  • Across the United States, 29 AdventHealth Hospitals earned an "A" rating in Fall 2023 from The Leapfrog Group.

For second time this year, Methodist Le Bonheur Healthcare adult hospitals rated safest in region

Retrieved on: 
Wednesday, November 8, 2023
Olive, Patient safety organization, System, Medicare, Mid-South, News, Health, Le Bonheur Children's Hospital, Injury, MLH, Safety, Overalls, Approximation error, Patient, Centers for Medicare & Medicaid Services, CMS, Infection, Hospital, Leapfrog

MEMPHIS, Tenn., Nov. 8, 2023 /PRNewswire/ -- When it comes to patient care in the Mid-South, Methodist Le Bonheur Healthcare continues to deliver the safest in the region, according to fall 2023 ratings by national watchdog The Leapfrog Group. Every Methodist Le Bonheur adult hospital received the highest rating possible – an "A".

Key Points: 
  • Every Methodist Le Bonheur adult hospital received the highest rating possible – an "A".
  • According to national Centers for Medicare and Medicaid Services (CMS) measures, Methodist Le Bonheur has the highest regional ratings for overall hospital quality.
  • To view Methodist Le Bonheur Healthcare's full grade details and see rates of other health systems, visit HospitalSafetyGrade.org .
  • For more updates from Methodist Le Bonheur Healthcare, follow us on Twitter , Facebook and LinkedIn .

El Camino Health Earns Straight 'A's' in Leapfrog Hospital Safety Grade Program

Retrieved on: 
Wednesday, November 8, 2023
Patient safety organization, Mountain View, Health, Leapfrog, Volunteering, Injury, Hospital, Accident, Patient safety, Safety, Approximation error, Mountain View Hospital (Payson, Utah), Patient, Infection, Nursing

MOUNTAIN VIEW, Calif., Nov. 8, 2023 /PRNewswire/ -- El Camino Health earned an 'A' Hospital Safety Grade for both the Mountain View and Los Gatos campuses from The Leapfrog Group, a national nonprofit watchdog that sets standards for excellence in patient care. El Camino Health is the only health system in the South Bay to have two hospitals receive the top grade.

Key Points: 
  • El Camino Health is the only health system in the South Bay to have two hospitals receive the top grade.
  • The Leapfrog Hospital Safety Grade is the only hospital ratings program exclusively based on hospital prevention of medical errors, infections, and injuries that kill more than 500 patients a day nationally.
  • "Earning an 'A' Grade means El Camino Health made a true commitment to put patients first," said Leah Binder, president and CEO of The Leapfrog Group.
  • To see El Camino Health's full grade details and to access patient tips for staying safe in the hospital, visit HospitalSafetyGrade.org .

Vigil Neuroscience Reports Third Quarter 2023 Financial Results and Provides Business Update

Retrieved on: 
Tuesday, November 7, 2023
FDA, Research, Data analysis, Research and development, AD, IGNITE, Half-life, Genetic testing, Event, Food, European Commission, Publication, European Medicines Agency, Microglia, CSF1R, MAD, Regulation of food and dietary supplements by the U.S. Food and Drug Administration, SAD, R, HCP, ANA, Approximation error, Civil service commission, Growth, Caregiver, PK, KOL, Medicine, EMA, TREM2, Patient, Administration, Investigational New Drug, Pharmaceutical industry, Cryptocurrency, IND, ALSP

WATERTOWN, Mass., Nov. 07, 2023 (GLOBE NEWSWIRE) -- Vigil Neuroscience, Inc. (Nasdaq: VIGL), a clinical-stage biotechnology company committed to harnessing the power of microglia for the treatment of neurodegenerative diseases, today announced financial results for the third quarter ended September 30, 2023, and provided an update on recent progress.

Key Points: 
  • In September, we also proudly introduced our oral small molecule TREM2 agonist candidate, VG-3927, with the opening of our IND.
  • Cash Position: Cash, cash equivalents, and marketable securities were $133.6 million as of September 30, 2023, compared to $150.2 million as of June 30, 2023.
  • General and Administrative (G&A) Expenses: G&A expenses for the third quarter ended September 30, 2023, were $6.9 million, compared to $4.8 million for the same period in 2022.
  • Net Loss: Loss from operations for the third quarter ended September 30, 2023, were $20.5 million, compared to $17.5 million for the same period in 2022.

First-Of-Its-Kind, Multi-National Patient Impact Survey Reveals Unique Challenges and Gaps in Care for Patients with Low-Grade Serous Ovarian Cancer

Retrieved on: 
Tuesday, November 7, 2023
Research, Women, FDA, Biotechnology, Health, Consumer, Pharmaceutical, Science, Oncology, Ovarian cancer, Knowledge, The Harris Poll, Massage chair, Education, Food, Mortality, Face, Regulation of food and dietary supplements by the U.S. Food and Drug Administration, Multimedia, HCP, Approximation error, Disease, World Health Organization, Classification, STAAR, Woman, Cancer, Anxiety, Patient, Diagnosis, Verastem Oncology, Pharmaceutical industry, Birth control

With no medicines specifically approved by the U.S. Food and Drug Administration for LGSOC, along with limited research and published data about the patient experience and its impact, managing this disease is challenging for healthcare professionals and patients.

Key Points: 
  • With no medicines specifically approved by the U.S. Food and Drug Administration for LGSOC, along with limited research and published data about the patient experience and its impact, managing this disease is challenging for healthcare professionals and patients.
  • This survey is an important collective effort to gather valuable insights and opinions to help better serve those living with LGSOC,” said Dr. David Gershenson, expert researcher in rare ovarian cancers and LGSOC Patient Impact Advisory Committee member.
  • These survey results underscore the urgency of educating on this unique form of ovarian cancer and provide important information to guide that effort.”
    Results from the survey revealed the challenges people with LGSOC face in obtaining a timely and accurate diagnosis.
  • Having this measurable, actionable data that sheds new light on the challenges we face because of LGSOC is an important step toward education and awareness that can hopefully improve care.”

Black Opal Ventures: Women-led VC Fund Investing in Technology to Revolutionize Industries

Retrieved on: 
Tuesday, November 7, 2023
Technology, Finance, Other Technology, Health Technology, Professional Services, Software, Health, Asset Management, Data Management, In-Q-Tel, Woman, Intelligence, Eli Lilly and Company, Bank, TigerGraph, Obesity, Investment, Artificial intelligence, Applied Materials, Bank of America, Strategic sustainable investing, Drug discovery, Neurology, Romeo Tanghal, Approximation error, Diagnosis, Infertility, BOV, Pharmaceutical industry, Financial services

Black Opal Ventures (BOV), founded by managing directors Dr. Tara Bishop and venture capitalist Eileen Tanghal, today announced their inaugural health-tech fund which has raised $58M to date.

Key Points: 
  • Black Opal Ventures (BOV), founded by managing directors Dr. Tara Bishop and venture capitalist Eileen Tanghal, today announced their inaugural health-tech fund which has raised $58M to date.
  • BOV believes this capital infusion will empower innovative early-stage companies at the intersection of healthcare and technology, heralding a new era of transformation in the healthcare industry.
  • "As investors, we see Black Opal Ventures as a trailblazing force in the health-tech sector,” said Brad Robling, VP Global Head of Lilly Ventures - Investing.
  • In addition to providing capital to these companies, Black Opal Ventures has assembled a network of industry experts, strategic partners, and resources to support these startups.

Medicus IT's Strength in eCW Application Support Continues to Transform Healthcare Clients

Retrieved on: 
Tuesday, November 7, 2023
Community, Education, Health care, Health information management, Medicus, Population health, ECW, Sunita, Electronic health record, EHR, Overalls, Approximation error, Nursing

ALPHARETTA, Ga., Nov. 7, 2023 /PRNewswire/ -- Medicus IT, a leading healthcare managed service provider, is pleased to announce they are reaffirming their strong commitment to healthcare IT, by expanding their capabilities nationally around electronic health records (EHRs), specifically eClinicalWorks (eCW) application support.

Key Points: 
  • ALPHARETTA, Ga., Nov. 7, 2023 /PRNewswire/ -- Medicus IT, a leading healthcare managed service provider, is pleased to announce they are reaffirming their strong commitment to healthcare IT, by expanding their capabilities nationally around electronic health records (EHRs), specifically eClinicalWorks (eCW) application support.
  • - Sunita Arora, COO
    Optimizing technology, enhancing quality and provider/patient experience is paramount to the way Medicus tailors customized solutions to fit client needs.
  • Medicus' growing team of highly skilled EHR optimization analysts work with providers to eliminate technical barriers.
  • Having a nationally known managed services IT provider focused exclusively on healthcare, like Medicus IT, supporting those efforts makes all the difference," said COO, Sunita Arora.

New AVMA Research Finds Pet Owners Overwhelmingly Prefer Veterinarian-Led Care for Their Pets

Retrieved on: 
Tuesday, November 7, 2023
Approximation error, AVMA, American Veterinary Medical Association, Collection, Pet, Physical examination, COVID-19, Sound, Telehealth, System, Diagnosis, Research, VCPR

SCHAUMBURG, Ill., Nov. 7, 2023 /PRNewswire/ -- The vast majority of pet owners believe that an in-person examination by a veterinarian leads to the best care for their pet and prefer to meet their veterinarian in-person before allowing them to care for their pet, according to results of a new survey released today by the American Veterinary Medical Association (AVMA).

Key Points: 
  • The AVMA's 2023 Pet Owner Attitude Survey was conducted to better understand animal owners' attitudes and experiences in the wake of disruptions caused by the COVID-19 pandemic.
  • Key takeaways include :
    "Pet owners want to feel confident that their animal companions are receiving the highest quality care.
  • This new research shows that pet owners have a clear preference for in-person and veterinarian-led care, which we know is the best option for animal health," said Dr. Rena Carlson, AVMA president.
  • The AVMA's survey was fielded online from September 8-14, 2023, and was completed by 1,000 pet owners across the United States.

MemorialCare Saddleback Medical Center Nationally Recognized with 'A' Leapfrog Hospital Safety Grade for the Seventh Time in a Row

Retrieved on: 
Monday, November 6, 2023
Patient safety organization, Health, Leapfrog, Physician, Volunteering, Injury, Accident, Safety, Approximation error, Patient, Infection, Nursing, Hospital

This is the seventh "A" grade in a row that Saddleback Medical Center has received to recognize its achievements in protecting patients from preventable harm and error in the hospital.

Key Points: 
  • This is the seventh "A" grade in a row that Saddleback Medical Center has received to recognize its achievements in protecting patients from preventable harm and error in the hospital.
  • "We are extremely grateful to be recognized for the extraordinary care provided by our exceptional Saddleback Medical Center physicians and care team members," says Marcia Manker, CEO, MemorialCare Saddleback Medical Center.
  • The Leapfrog Hospital Safety Grade is the only hospital ratings program exclusively based on hospital prevention of medical errors, infections and injuries that kill more than 500 patients a day nationally.
  • To see MemorialCare Saddleback Medical Center's full grade details and to access patient tips for staying safe in the hospital, visit HospitalSafetyGrade.org .

A Senate inquiry says Australia needs a national ADHD framework to improve diagnosis and reduce costs

Retrieved on: 
Tuesday, November 7, 2023
Practitioner, Policy, Ageing, Education, GP, Government, Medicare, Research, PBS, Approximation error, Quality of life, First Nations, NDIS, University, Employment, Awareness, School, Guideline, Woman, Senate, Diagnosis, Pharmaceutical Benefits Scheme, Prison, National Disability Insurance Scheme, Attention deficit hyperactivity disorder predominantly inattentive, Dietary supplement, Nursing, ADHD

Without appropriate support, ADHD often has lifelong negative impacts on education and employment.

Key Points: 
  • Without appropriate support, ADHD often has lifelong negative impacts on education and employment.
  • The current cost of ADHD to Australia is estimated at more than A$20 billion every year.
  • In response to these concerns, a Greens-chaired Senate inquiry looked at how people access ADHD diagnosis and get support afterwards, the international evidence base, as well as practitioner training and cost.

Not just a mental health issue

  • The committee emphasises that ADHD is not just a mental health issue but a public health concern.
  • The committee members agreed there is a need for a government-funded national framework for ADHD, developed in consultation with people with lived experience.
  • They recommended the NDIS improve the accessibility and quality of information around the eligibility of ADHD as a condition under NDIS.


Read more:
GPs could improve access to ADHD treatment. But we still need specialists to diagnose and start medication

Learning from people with ADHD

  • Trying to navigate pathways to care, even as an expert in ADHD, can be challenging and at times painful in my experience.
  • While public awareness of ADHD has improved greatly in recent years there are still those spreading misinformation and increasing the stigma of people living with ADHD.
  • Read more:
    ADHD medications have doubled in the last decade – but other treatments can help too

A first step

  • The committee recommends
    all levels of government consider investing in the implementation of the Australian ADHD Professionals Association’s Australian evidence-based clinical practice guideline for ADHD.
  • all levels of government consider investing in the implementation of the Australian ADHD Professionals Association’s Australian evidence-based clinical practice guideline for ADHD.
  • Further investment will be needed to ensure the guideline is used properly to promote more holistic care with broader access to key supports.


David Coghill receives funding from the National Health and Medical Research Council and the Medical Research Futures Fund. He is the President of the Australian ADHD Professionals Association and a director of the European ADHD Guidelines Network both not for profit organizations working in the field of ADHD. He has received research funding and/or honoraria from Takeda, Medice, Novartis and Servier.